4502.T

Takeda Pharmaceutical Company Limited JPX · 4502.T

$5,552.00 -3.00 (-0.05%)

Blow-off · +2.02σ Hot zone Grade C

+ Compare Open in Sniper

Mkt cap $8,865.2B

P/E —

Day $5471.00 – $5589.00

52wk $4710.00 – $6033.00

Avg vol 4.2M

Beta 0.09

Div yld 3.67%

Next earnings 2026-07-30

Quick read

At a glance

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.

4502.T last traded at $5,552, down 0.1% on the day; that's in the middle part of its 52-week range ($4,710–$6,033). Right now it's stretched well above its recent average — moves this fast often cool off or give some back.

The next scheduled earnings report (2026-07-30) is the biggest known catalyst on the calendar, and after a strong run, watch whether the price can hold its gains on quieter days.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

Price is stretched well above its normal range — a standard stretch that often pulls back toward normal. Plus a doji candle — buyers and sellers fought to a draw, which often comes right before a turn.

Long —

Setup score 22 / 100

Price is sitting close to its normal range — no real dip to buy yet. Doji candle.

· Doji — indecision, watch for reversal
· Aligned with strong uptrend (strong tailwind)

Technical read: above KC1 lower, +1.97 ATR from EMA21 · doji

What it means: Price is sitting close to its normal range — no real dip to buy yet. The trigger bar shows a doji candle — buyers and sellers fought to a draw, which often comes right before a turn.

Score split: chart signals 22 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 22 pts

Cycle position 6

Candle signal 6

Market fit 10

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short C

Setup score 34 / 100

Price is stretched well above its normal range — a standard stretch that often pulls back toward normal. Doji candle.

ℹ️ Stretched (KC2): stop is set a little wider to avoid a whipsaw, so the reward/risk reads a bit lower by design.

· KC2 upper stretch — standard mean-reversion tier
· Doji — indecision, watch for reversal
· RSI hook from overbought (67)

Technical read: KC2 upper, +1.97 ATR from EMA21 · doji

What it means: Price is stretched well above its normal range — a standard stretch that often pulls back toward normal. The trigger bar shows a doji candle — buyers and sellers fought to a draw, which often comes right before a turn.

Score split: chart signals 34 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 34 pts

Cycle position 22

Candle signal 6

Momentum 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Key statistics

All statistics →

4502.T is a $8.9 trillion company, it moves more calmly than the market (beta 0.1).

Market cap $8,865.2B

P/E ttm —

Beta 0.09

52w range $4710.00 – $6033.00

Avg volume 4.2M

Dividend yield 3.67%

Sector Healthcare

Next earnings 2026-07-30

52-week range · today's price

$4710.00$6033.00

More on 4502.T

Earnings

See more →

Last reported: 2026-05-13
EPS (act / est): -15.31 / -24.01
Surprise: +36.2%
Next report: 2026-07-30

About

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti,…